Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
SUZHOU, China and ROCKVILLE, Md., March 9, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the results from six preclinical studies of the company's five drug candidates: the Bcl-2 inhibitor lisaftoclax (APG-2575) and the...
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer
SEATTLE, Wash. and SUZHOU, China, March 9, 2022 /PRNewswire/ -- ProfoundBio announced that preclinical data from its pipeline of novel, proprietary antibody-drug conjugates (ADCs) and technology will be presented at the American Association for Cancer Research (AACR) Annual Meeting being held April 8 -- 13, 2022. The presentations will highlight three late-stage preclinical programs utilizing ProfoundBio's leading ADC technology as well...
Omega Healthcare Acquires Reventics, a Physician Focused CDI and RCM Company
BOCA RATON, Fla., March 9, 2022 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the broad healthcare ecosystem, today announced its acquisition of Reventics, a Denver, CO based company. Reventics is a clinical documentation improvement ("CDI") and revenue cycle management ("RCM") solutions provider that delivers Provider Engagement Solutions to enhance physician reimbursement and compliance, while improving...
FIRST SURGERIES COMPLETED WITH PATIENT-SPECIFIC 3D PRINTED IMPLANTS PRODUCED AT THE LIMACORPORATE PROMADE POINT OF CARE CENTER AT HOSPITAL FOR SPECIAL SURGERY
UDINE, Italy, March 9, 2022 /PRNewswire/ -- LimaCorporate S.p.A., leading global orthopedics manufacturer, and Hospital for Special Surgery (HSS), consistently ranked number one in orthopedics globally by Newsweek and nationally by U.S. News & World Report in the U.S., today announced a new milestone in their collaboration. The first patient-specific solutions designed...
Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space
NEW YORK, March 9, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran") has entered into an agreement with the University of Maryland, Baltimore ("UMB") for a worldwide exclusive license to develop and commercialize a portfolio of UMB's patents and data to support a novel approach to the treatment of neurological and psychiatric...
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022
Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antigen receptor (CAR) T cell therapy PALO ALTO, Calif. and SUZHOU, China, March 9, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell...
MediTrust Health invited three women who are fighting with diseases to share their views for March 8th Women’s Day
SHANGHAI, March 8, 2022 /PRNewswire/ -- As the Women's Day is approaching, MediTrust Health invited three women who are fighting with diseases to share their views on one question - why do we need to live a sparkling life. We hope their answers will inspire and encourage those who are struggling with severe diseases, and give them more courage to...
Femtech after COVID-19: How to Break the Bias and Meet Women’s Untapped Healthcare Needs in 2022
On International Women's Day, Frost & Sullivan leads the discussion on women's unique healthcare needs using femtech SAN ANTONIO, March 8, 2022 /PRNewswire/ -- The pandemic has revealed the glaring gaps in women's healthcare and emphasized the need to build a more equitable system. This International Women's Day, Frost & Sullivan acknowledges the role played by female technology (femtech) solutions...
Digitalization and Innovative Business Models Key to Transformational Growth in APAC, Finds Frost & Sullivan
Organizations should integrate their existing core expertise with new technology capabilities to drive innovation SINGAPORE, March 8, 2022 /PRNewswire/ -- As the impact of digitalization advances across all sectors, businesses are at a crucial turning point. They must optimize the returns from their existing resources while embracing new business models to create greater value for customers amid a challenging...
SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark
COPENHAGEN, Denmark, March 8, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is opening a 175 square meter state-of-the-art BSL2/GMO2-classified laboratory in Copenhagen. The new facilities will be among the largest GMO2 laboratories in Scandinavia and Northern Europe with the capacity to handle clinical samples from the phase 1 clinical trial with SNIPR001 and...
